Low-Dose Dasatinib in Older Patients With CML in Chronic Phase
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial
Lancet Haematol 2021 Dec 01;8(12)e902-e911, K Murai, H Ureshino, T Kumagai, H Tanaka, K Nishiwaki, S Wakita, K Inokuchi, T Fukushima, C Yoshida, N Uoshima, T Kiguchi, M Mita, J Aoki, S Kimura, K Karimata, K Usuki, J Shimono, Y Chinen, J Kuroda, Y Matsuda, K Nakao, T Ono, K Fujimaki, H Shibayama, C Mizumoto, T Takeoka, K Io, T Kondo, M Miura, Y Minami, T Ikezoe, J Imagawa, A Takamori, A Kawaguchi, J Sakamoto, S KimuraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.